In addition, studies have shown that fasudil treatment is able to improve cognitive dysfunction in stroke and Alzheimer’s disease by inhibiting the hippocampal ROCK/cofilin pathway [42, 43], and these pieces of evidence provide strong support for our findings that fasudil can ameliorate cognitive dysfunction after CSR. Here, CFL1 is linked to early-onset autosomal dominant Alzheimer disease.